This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Palau Pharma, S.A.
Drug Names(s): dersalazine sodium
Deal Structure: In September 2001, Indevus licensed exclusive, worldwide rights to dersalazine from Uriach, in exchange for an up-front licensing payment and potential development milestone and royalty payments to Uriach (Palau). In 2003, Indevus returned rights to Palau Pharma.
Additional information available to subscribers only: